Stents Farmacológicos para Todos: o Preço Vale a Pena? / Drug-Eluting Stents for Everyone: Is the Price Worth It?
Arq. bras. cardiol
; 115(1): 90-91, jul. 2020.
Article
in Portuguese
| LILACS, Sec. Est. Saúde SP
| ID: biblio-1131270
Responsible library:
BR1.1
Subject(s)
Análise de Custo Benefício; Coronary Reestenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Infarto do Miocárdio; Intervenção Coronária Percutânea; Myocardial Infarction; Percutaneous Coronary Intervention; Reestenose Coronária; Sistema Único de Saúde (SUS; Stents Farmacológicos; Unified Health System (SUS)
Full text:
Available
Collection:
National databases
/
Brazil
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 4: Health financing
/
Goal 5: Medicines, vaccines and health technologies
Database:
LILACS
/
Sec. Est. Saúde SP
Main subject:
Coronary Restenosis
/
Drug-Eluting Stents
/
Percutaneous Coronary Intervention
Type of study:
Health economic evaluation
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Journal:
Arq. bras. cardiol
Year:
2020
Document type:
Article
Institution/Affiliation country:
Hospital Israelita Albert Einstein/BR
/
Universidade Federal de São Paulo/BR
